Picture of Prestige Consumer Healthcare logo

PBH — Prestige Consumer Healthcare News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

US FDA approves Vanda Pharmaceuticals' motion sickness drug

Dec 30 (Reuters) - The U.S. Food and Drug Administration has approved Vanda Pharmaceuticals' VNDA.O drug for the prevention of vomiting induced by motion, the company said on Tuesday.

 (Reporting by Siddhi Mahatole and Puyaan Singh in Bengaluru; Editing by Shilpi Majumdar)

 ((siddhi.mahatole@thomsonreuters.com;))

Recent news on Prestige Consumer Healthcare

See all news